GNI Group (FRA:3G6) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3G6 GNI Group Ltd FRA:3G6
86 GF Score
Price €13.40
GF Value €15.65
! 5 Warning Signs
View Full Analysis

What is GNI Group Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:3G6
86GF Score
GNI Group Ltd FRA:3G6
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GNI Group (FRA:3G6) Overvalued in 2026?

Based on GuruFocus' analysis, GNI Group stock appears to be undervalued. The current stock price of €13.40 is trading 14.4% below its estimated GF Value™ of €15.65.

Key valuation signals for FRA:3G6:

  • Short Ratio:
  • GF Value™: €15.65 vs. price of €13.40 (14.4% below fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the FRA:3G6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GNI Group Business Description

Other Exchanges 2160:Japan
Address 2-2-2 Nihonbashi Honcho, 3rd Floor, Nihonbashi Honcho YS Building, Chuo-ku, Tokyo, JPN, 103-0023
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
86GF Score

Get the complete analysis for FRA:3G6

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.40
Price
€15.65
GF Value